drugset / Trial / NCT02287246

Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Urogynecologic Surgery

NCT02287246 ↗

Phase 4 Unknown 120 enrolled Walter Reed National Military Medical Center
RandomizedSingle-groupDouble-blindTreatment

Summary

To study post-operative efficacy of Exparel® for pain control in patients undergoing any Urogynecology surgery involving the posterior vaginal wall using a randomized, double-blinded placebo controlled trial.

Timeline

Start
2014-10
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.